Cleared Traditional

K914204 - TRI-POINT LIQUIMMUNE LIGAND CONTROL LEV...

K914204 is the FDA 510(k) clearance for TRI-POINT LIQUIMMUNE LIGAND CONTROL LEV... by Medical Analysis Systems, Inc.. It is a Class 1 Chemistry device (product code JJY) cleared through the Traditional 510(k) pathway after a 180-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1992
Decision
180d
Days
Class 1
Risk

K914204 is an FDA 510(k) clearance for the TRI-POINT LIQUIMMUNE LIGAND CONTROL LEVELS 1,2,3. Classified as Multi-analyte Controls, All Kinds (assayed) (product code JJY), Class I - General Controls.

Submitted by Medical Analysis Systems, Inc. (Camarillo, US). The FDA issued a Cleared decision on March 17, 1992 after a review of 180 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Medical Analysis Systems, Inc. devices

Submission Details

510(k) Number K914204 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 19, 1991
Decision Date March 17, 1992
Days to Decision 180 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
92d slower than avg
Panel avg: 88d · This submission: 180d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JJY Multi-analyte Controls, All Kinds (assayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJY Multi-analyte Controls, All Kinds (assayed)

All 463
Devices cleared under the same product code (JJY) and FDA review panel - the closest regulatory comparables to K914204.
AMERLITE FREE THYROID CONTROL SERA LAN.4002
K920940 · Eastman Kodak Company · Apr 1992
HUMAN CHORIONIC GONADATROPHIN AND UNCON. ESTRIOL
K920826 · Eastman Kodak Company · Apr 1992
CHEM-CHEM MULTI-ANALYTE (MODIFIED)
K920350 · Streck Laboratories, Inc. · Mar 1992
N/T PROTEIN CONTROL UY
K914890 · Behring Diagnostics, Inc. · Feb 1992
LIQUICHEK(R) UNASSAYED CHEMISTRY CONTR(HUMAN) 1&2
K914255 · Bio-Rad · Jan 1992
RAI-TROL ELEVATED LIPIDS CONTROL
K915191 · Reagents Applications, Inc. · Dec 1991